Tumor growth rate (TGR) to monitor growth/predict response to lanreotide autogel use before, during and after PRRT in advanced GEP-NETS: data from the PRELUDE study
Bodei, L Srirajaskanthan, R Grana, CM Baldari, S Shah, T Lamarca, Angela Courbon, F Scheidhauer, K Baudin, E Roussy, G
Bodei, L
Srirajaskanthan, R
Grana, CM
Baldari, S
Shah, T
Lamarca, Angela
Courbon, F
Scheidhauer, K
Baudin, E
Roussy, G
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2020
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Bodei L, Srirajaskanthan R, Grana C, Baldari S, Shah T, Lamarca A, et al. Tumor growth rate (TGR) to monitor growth/predict response to lanreotide autogel use before, during and after PRRT in advanced GEP-NETS: data from the PRELUDE study. Pancreas. 2020;49(3):464-